Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 01, 2008 (Vol. 28, No. 19)

History of Medicine

  • Breadth of coverage
  • Nothing significant
From the Karolinska Institute comes the History of Medicine site. If you think back to the first history class you ever took in high school, you probably didn’t like it because it gave you a list of dates to memorize and didn’t really capture what history was all about. That thought came to my mind as I perused the History of Medicine site, which presented a similar sort of list of options after I clicked on each of the hyperlinks on the site’s opening page. Fortunately, clicking on them brings up more readable and interesting content. I don’t mean to belittle this site, because a well-organized historical site is going to have a front end of links (as this one does) and secondary information that is more readable. The question here is whether the secondary info is actually interesting, and for that I shout a resounding yes. The coverage here is absolutely outstanding, and there is more interesting material here than you will read in several long sittings. Though I’d like to see other organizational options such as a timeline, History of Medicine delivers on its subject.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »